8-K filing — Strata Critical Medical, Inc. (SRTA)
Filed: 2026-11-03 AccNo: 0001628280-26-069117 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Strata Critical Medical, Inc. reported its financial results for the third quarter ended September 30, 2026, highlighting a 50.3% year-over-year revenue increase and a new share repurchase authorization.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Filed: 2026-11-03 AccNo: 0001628280-26-069117 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Investment firm Third Point has filed an initial 13D regarding its stake in Strata Critical Medical, signaling a shift to an activist investor stance.
Strata Critical Medical, Inc. announced it will release its financial results for the third quarter ended September 30, 2026, on November 3, 2026.
U.S. stocks fell Friday, led by Nasdaq’s 1.86% drop; energy rose, communication services sank. Oil topped $100 as CFG beat earnings estimates.
U.S. stocks were mixed; Ladder Capital surged after beating Q3 estimates. Alcoa and other stocks also gained, led by Strata Critical Medical’s 7.5% rise.